Annual Cash & Cash Equivalents
$119.89 M
+$59.98 M+100.09%
31 December 2023
Summary:
Ikena Oncology annual cash & cash equivalents is currently $119.89 million, with the most recent change of +$59.98 million (+100.09%) on 31 December 2023. During the last 3 years, it has fallen by -$42.60 million (-26.21%). IKNA annual cash & cash equivalents is now -48.37% below its all-time high of $232.22 million, reached on 31 December 2021.IKNA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$45.19 M
+$922.00 K+2.08%
30 September 2024
Summary:
Ikena Oncology quarterly cash and cash equivalents is currently $45.19 million, with the most recent change of +$922.00 thousand (+2.08%) on 30 September 2024. Over the past year, it has dropped by -$76.09 million (-62.74%). IKNA quarterly cash and cash equivalents is now -83.92% below its all-time high of $281.01 million, reached on 31 March 2021.IKNA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKNA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.1% | -62.7% |
| 3 y3 years | -26.2% | -81.6% |
| 5 y5 years | - | - |
IKNA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.4% | +100.1% | -81.6% | +54.1% |
| 5 y | 5 years | -48.4% | +100.1% | -83.9% | +54.1% |
| alltime | all time | -48.4% | +100.1% | -83.9% | +54.1% |
Ikena Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $45.19 M(+2.1%) |
| June 2024 | - | $44.27 M(-16.2%) |
| Mar 2024 | - | $52.85 M(-55.9%) |
| Dec 2023 | $119.89 M(+100.1%) | $119.89 M(-1.1%) |
| Sept 2023 | - | $121.28 M(+71.1%) |
| June 2023 | - | $70.87 M(+141.6%) |
| Mar 2023 | - | $29.33 M(-51.1%) |
| Dec 2022 | $59.92 M | $59.92 M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $67.07 M(+38.3%) |
| June 2022 | - | $48.49 M(+3.4%) |
| Mar 2022 | - | $46.88 M(-79.8%) |
| Dec 2021 | $232.22 M(+42.9%) | $232.22 M(-5.6%) |
| Sept 2021 | - | $245.90 M(-6.9%) |
| June 2021 | - | $264.00 M(-6.1%) |
| Mar 2021 | - | $281.01 M(+72.9%) |
| Dec 2020 | $162.49 M(+98.0%) | $162.49 M |
| Dec 2019 | $82.08 M | - |
FAQ
- What is Ikena Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ikena Oncology?
- What is Ikena Oncology annual cash & cash equivalents year-on-year change?
- What is Ikena Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ikena Oncology?
- What is Ikena Oncology quarterly cash and cash equivalents year-on-year change?
What is Ikena Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of IKNA is $119.89 M
What is the all time high annual cash & cash equivalents for Ikena Oncology?
Ikena Oncology all-time high annual cash & cash equivalents is $232.22 M
What is Ikena Oncology annual cash & cash equivalents year-on-year change?
Over the past year, IKNA annual cash & cash equivalents has changed by +$59.98 M (+100.09%)
What is Ikena Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IKNA is $45.19 M
What is the all time high quarterly cash and cash equivalents for Ikena Oncology?
Ikena Oncology all-time high quarterly cash and cash equivalents is $281.01 M
What is Ikena Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, IKNA quarterly cash and cash equivalents has changed by -$76.09 M (-62.74%)